“What’s natural is the microbe. All the rest-health, integrity, purity (if you like)-is a product of the human will, of a vigilance that must never falter.”

The Plague by Albert Camus, French author

SARS. MERS. Ebola. These are familiar names of recent pandemics that strike fear even amongst seasoned global healthcare workers even though the combined mortality (774, 38, and 11325 deaths respectively for a total of 12,137) was less than the number of people who have already succumbed to the current coronavirus pandemic (18,605 worldwide including over 700 in the US of as March 24th).

The ongoing coronavirus disease 2019 (COVID-19) is a serious respiratory disease as a result of infection from the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)(Note: the former describes the disease entity from the latter which is the name of the virus). COVID-19 as a disease is manifested by fever, fatigue, cough, and shortness of breath and the main pathology is ground-glass lesions in the subpleural areas of the lungs with progression to consolidation.

AIMed will be publishing a multi-part discussion of how artificial intelligence will need to be part of global health in its fight against present and future pandemics. First, an epidemiology and pandemic primer frames the ensuing three-part discussion. The first segment focuses on current strategies for overcoming a pandemic and how countries have performed to date. The second section discusses the early lessons learned during this pandemic and how these lessons are relevant to data science and artificial intelligence. The third and last part delineates how artificial intelligence will be leveraged as an essential partner for human clinicians and global healthcare in the future for pandemics.

Anthony Chang, MD, MBA, MPH, MS
Founder, AIMed
Chief Intelligence and Innovation Officer
Medical Director, The Sharon Disney Lund
Medical Intelligence and Innovation Institute (mi3)
Children’s Hospital of Orange County